Evidence map›Paper›PMID 34947733›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Preparation and Characterization of Photocatalytically Active Antibacterial Surfaces Covered with Acrylic Matrix Embedded Nano-ZnO and Nano-ZnO/Ag.

Merilin Rosenberg, Meeri Visnapuu, Kristjan Saal, Dmytro Danilian, Rainer Pärna, Angela Ivask, Vambola Kisand

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Antimicrobial Nano Coatings.Nanomaterials (Basel, Switzerland) · 2022
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Merilin RosenbergInstitute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010 Tartu, Estonia.
Meeri VisnapuuInstitute of Physics, University of Tartu, W. Ostwaldi Str. 1, 50411 Tartu, Estonia.ORCID 0000-0003-0028-7083
Kristjan SaalInstitute of Physics, University of Tartu, W. Ostwaldi Str. 1, 50411 Tartu, Estonia.
Dmytro DanilianInstitute of Physics, University of Tartu, W. Ostwaldi Str. 1, 50411 Tartu, Estonia.
Rainer PärnaInstitute of Physics, University of Tartu, W. Ostwaldi Str. 1, 50411 Tartu, Estonia.
Angela IvaskInstitute of Molecular and Cell Biology, University of Tartu, Riia 23, 51010 Tartu, Estonia.ORCID 0000-0003-3451-7211
Vambola KisandInstitute of Physics, University of Tartu, W. Ostwaldi Str. 1, 50411 Tartu, Estonia.ORCID 0000-0001-9765-055X
University of Tartu · EETallinn University of Technology · EE

Funding

Estonian Research Council EAG20, COVSG2, MOBTP145Estonian Research Council Estonian Centre of Excellence in Research project "Advanced materials and high-technology devices for sustainable energetics, sensorics and nanoelectronics" TK141 (2014-2020.4.01.15-0011)University of Tartu Development Fund PLTFYARENG53
6 · The paper itself

Abstract

In the context of healthcare-acquired infections, microbial cross-contamination and the spread of antibiotic resistance, additional passive measures to prevent pathogen carryover are urgently needed. Antimicrobial high-touch surfaces that kill microbes on contact or prevent their adhesion could be considered to mitigate the spread. Here, we demonstrate that photocatalytic nano-ZnO- and nano-ZnO/Ag-based antibacterial surfaces with efficacy of at least a 2.7-log reduction in

Indexed as

antimicrobialEscherichia coliplywood lacquerStaphylococcus aureus

Identifiers

PMID34947733
PMCPMC8703771
OpenAlexW4200517071

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.